CSBR SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Sep 11, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Jul 27, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Mar 12, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dec 15, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Sep 15, 2025

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Jul 23, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Champions Oncology, Inc. Reports Voting Results from its 2026 Annual Meeting of Stockholders

Oct 16, 2026

8-K

Champions Oncology Reports First Quarter Fiscal 2027 Financial Results with $15.2 Million in Revenue

Sep 10, 2026

8-K

Champions Oncology Reports Record Annual Revenue of $59 Million and Positive Adjusted EBITDA for Fiscal Year 2026

Jul 27, 2026

8-K

Champions Oncology Appoints Dr. Brian Alexander to Board of Directors

Mar 30, 2026

8-K

Champions Oncology Reports Third Quarter Fiscal 2026 Financial Results

Mar 12, 2026

8-K

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

Dec 15, 2025

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Oct 30, 2024

S-1/A

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

May 23, 2016

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933

Apr 25, 2016

POS AM

Form POS AM - Post-Effective amendments for registration statement

Sep 25, 2015

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Aug 20, 2015

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933

May 11, 2015

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Aug 28, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Aug 28, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Aug 22, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Aug 22, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Aug 27, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Aug 27, 2024

Ownerships

TYPE

HEADLINE

FILED AT

NEWSIDRANSKY DAVID (Reporting)

Nov 9, 2026

NEWMendelson Daniel Newman (Reporting)

Nov 9, 2026

NEWTOBIN SCOTT R (Reporting)

Nov 9, 2026

NEWACKERMAN JOEL (Reporting)

Nov 9, 2026

ACKERMAN JOEL (Reporting)

Oct 16, 2026

Brainin Robert Lawrence (Reporting)

Jan 30, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Mar 4, 2025

CORRESP

Form CORRESP - Correspondence

Mar 3, 2025

LETTER

Form UPLOAD - SEC-generated letter

Feb 26, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 10, 2016

CORRESP

Form CORRESP - Correspondence

Jun 8, 2016

CORRESP

Form CORRESP - Correspondence

Jun 8, 2016

Champions Oncology, Inc. CSBR · SEC Filings